The FDA has approved deuruxolitinib as a first-line treatment for adults with moderate to severe alopecia areata (AA). 1 Deuruxolitinib, developed by Sun Pharma, is an oral selective inhibitor of ...

KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that the U.S. Food and Drug Administration (FDA) has approved EKTERLY® (sebetralstat), a novel ...

Dr. Hing C. Wong, Founder and CEO of HCW Biologics, expressed optimism about the trial, stating, "The FDA's clearance to initiate our first-in-human clinical trial for HCW9302 brings us one step ...

With conflicting reports and cost considerations, Black women are demanding clarity: Which hair regrowth procedure truly ...